GN

Gunnar Nilsson Cancer Foundation

Description

Gunnar Nilsson Cancer Foundation

Investor Profile

Gunnar Nilsson Cancer Foundation has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed rounds (top funding stages).
  • Majority of deals are located in Sweden.
  • Strong thematic focus on Biotechnology, Genetics, Medical.

Stage Focus

  • Series A (50%)
  • Seed (50%)

Country Focus

  • Sweden (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Medical
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gunnar Nilsson Cancer Foundation frequently co-invest with?

Hadean Ventures
Europe, Oslo, Norway, Oslo
Co-Investments: 1
Faro Capital
South America, Distrito Federal, Argentina, Buenos Aires
Co-Investments: 1
TK
Europe, Skane Lan, Sweden, Lund
Co-Investments: 1

Which angels does Gunnar Nilsson Cancer Foundation often collaborate with?

SF
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Gunnar Nilsson Cancer Foundation?

SAGA Diagnostics

Lund, Skane Lan, Sweden

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

BiotechnologyGeneticsMedicalOncology
Series AJun 11, 2019
Amount Raised: $4,234,029
SAGA Diagnostics

Lund, Skane Lan, Sweden

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

BiotechnologyGeneticsMedicalOncology
SeedMar 15, 2018
Amount Raised: $1,230,750